Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Table S2 from Inhibition of MCL-1 and MEK Overcomes MEK Inhibitor Resistance in Triple-Negative and Inflammatory Breast Cancers
  1. Home
  2. Publications
  3. Table S2 from Inhibition of MCL-1 and MEK Overcomes MEK Inhibitor Resistance in Triple-Negative and Inflammatory Breast Cancers

Table S2 from Inhibition of MCL-1 and MEK Overcomes MEK Inhibitor Resistance in Triple-Negative and Inflammatory Breast Cancers

Authors:
  • MMMohd Mughees
    Mohd Mughees
  • MTMoises Tacam
    Moises Tacam
  • ATAlex W. Tan
    Alex W. Tan
  • MPMary Kathryn Pitner
    Mary Kathryn Pitner
  • LILakesla R. Iles
    Lakesla R. Iles
  • XHXiaoding Hu
    Xiaoding Hu
  • EVEmilly S. Villodre
    Emilly S. Villodre
  • BDBisrat G. Debeb
    Bisrat G. Debeb
  • TKTakahiro Kogawa
    Takahiro Kogawa
  • BLBora Lim
    Bora Lim
  • RLRachel M. Layman
    Rachel M. Layman
  • WWWendy A. Woodward
    Wendy A. Woodward

Open Access
Publisher website
Google Scholar
  • 2 September 2025
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1535-7163.30029531
Abstract
Table S2 List of top 26 targets identified in the whole-genome siRNA screening.
Keywords
  • BREAST CANCER
  • CELL SIGNALING
  • DRUG RESISTANCE
  • TRANSLATIONAL RESEARCH
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.